Santhera Pharmaceuticals Holding Ag (0QN1)
LSE
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
CHF (CHF) | CHF (CHF) | CHF (CHF) | CHF (CHF) | CHF (CHF) | CHF (CHF) | CHF (CHF) | CHF (CHF) | |
Return on Assets (%) | -34.062 | -51.385 | -49.243 | -16.839 | -66.418 | -61.763 | -91.804 | 63.202 |
Return on Equity (%) | -39.22 | -96.677 | -180.364 | -77.321 | -908.601 | 2209.55 | 335.597 | 673.95 |
Return on Invested Capital (%) | -36.652 | -62.68 | -61.606 | -9.966 | -73.517 | -133.15 | -717.762 | 250.259 |
Operating Margin (%) | -174.324 | -206.738 | -155.931 | -16.334 | -355.097 | 2185.266 | -672.742 | 77.693 |
Net Profit Margin (%) | -186.072 | -224.609 | -171.166 | -25.171 | -450.82 | 3481.254 | -951.104 | 52.973 |
Book Value Per Share | 7.617 | 1.385 | -3.154 | -3.335 | -4.083 | -1.276 | -1.366 | -1.239 |
Earnings Per Share | -5.643 | -8.207 | -5.081 | -1.699 | -3.732 | -1.12 | -0.944 | 4.842 |
Cash Per Share | 7.937 | 7.198 | 2.06 | 2.809 | 0.685 | 0.428 | 0.018 | 2.684 |
Working Capital Per Share | 8.3 | 10.25 | 2.192 | 2.265 | -0.626 | -0.164 | -0.615 | -0.854 |
Operating Profit Per Share | 2.992 | 3.582 | 2.842 | 6.561 | 0.458 | -0.039 | 0.096 | 9.128 |
EBIT Per Share | -5.289 | -8.166 | -5.051 | -1.647 | -3.721 | -1.103 | -0.938 | 4.845 |
EBITDA Per Share | -5.289 | -8.166 | -5.051 | -1.647 | -3.721 | -1.103 | -0.938 | 4.845 |
Free Cash Flow Per Share | -6.103 | -8.523 | -3.402 | -2.106 | -3.983 | -1.195 | -0.94 | 6.671 |
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 6,28M | 6,28M | 10,67M | 11,17M | 18,13M | 49,59M | 75,32M | 11,32M |
Capitalisation boursière | 2,15B |
Ratio cours/bénéfice | 1,95 |
Ratio prix/ventes | 1,03 |
Ratio prix/liquidités | 3,51 |
Ratio prix/valeur comptable | 1,78 |
Rendement de dividende | - |
Actions en circulation | 11,32M |
Volume moyen (1 semaine) | 2,28k |
Volume moyen (1 mois) | 1,29k |
Variation sur 52 semaines | 0,00% |
Plus haut sur 52 semaines | 190,20 |
Plus bas sur 52 semaines | 190,20 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales